Immune Checkpoint Inhibitor-Induced Limbic Encephalitis during Treatment with Atezolizumab in a Patient with Small-Cell Lung Cancer: A Case Report and Review of the Literature

<div>Fluid-attenuated inversion recovery (FLAIR) image of brain magnetic resonance imaging (MRI) before initiation of treatment with immune checkpoint inhibitor reveals no abnormal finding.</div>

Case Reports in Immunology

fig1

Figure 1

Figure 1: Immune Checkpoint Inhibitor-Induced Limbic Encephalitis during Treatment with Atezolizumab in a Patient with Small-Cell Lung Cancer: A Case Report and Review of the Literature 

Figure 1 | Immune Checkpoint Inhibitor-Induced Limbic Encephalitis during Treatment with Atezolizumab in a Patient with Small-Cell Lung Cancer: A Case Report and Review of the Literature 